ahlam1399
09-02-2015, 01:41 AM
CORRECTED-Alexion gets EU approval for drug acquired in Synageva deal
NEW YORK, Sept 1 (Reuters) - Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday an**unced European approval for the key drug acquired...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=Ki63C8sKYSk:zrICjoqhSl4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=Ki63C8sKYSk:zrICjoqhSl4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=Ki63C8sKYSk:zrICjoqhSl4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=Ki63C8sKYSk:zrICjoqhSl4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=Ki63C8sKYSk:zrICjoqhSl4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/Ki63C8sKYSk
NEW YORK, Sept 1 (Reuters) - Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday an**unced European approval for the key drug acquired...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=Ki63C8sKYSk:zrICjoqhSl4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=Ki63C8sKYSk:zrICjoqhSl4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=Ki63C8sKYSk:zrICjoqhSl4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=Ki63C8sKYSk:zrICjoqhSl4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=Ki63C8sKYSk:zrICjoqhSl4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/Ki63C8sKYSk